title: [Immunologic differences of triple-negative and luminal A breast cancer].
authors.forename: D Iu
authors.initials: DIu
authors.lastname: Mel'nikov
authors.forename: I V
authors.initials: IV
authors.lastname: Pushina
authors.forename: Iu G
authors.initials: IuG
authors.lastname: Lagereva
authors.forename: Ia B
authors.initials: IaB
authors.lastname: Beĭkin
authors.forename: I Iu
authors.initials: IIu
authors.lastname: Ivanova
mesh_terms: D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000276:immunology; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry / Q000276:immunology* / Q000473:pathology; D005260:Female; D006098:Granulocytes / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology; D007376:Interleukin-2 / Q000276:immunology; D007962:Leukocytes / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D008875:Middle Aged; D009367:Neoplasm Staging; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D015703:Antigens, CD; D014408:Biomarkers, Tumor; D007371:Interferon-gamma; D007376:Interleukin-2; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D014409:Tumor Necrosis Factor-alpha; C508053:ERBB2 protein, human